3-甲基-2-硝基苄醇 | 80866-76-8

• 物质功能分类: 化学试剂 - 有机试剂 - 芳烃
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-甲基-2-硝基苄醇
• 中文别名: 3-甲基-2-硝基苯甲醇
• 英文名称: (3-methyl-2-nitrophenyl)methanol
• 英文别名: 3-methyl-2-nitrobenzyl alcohol；2-methyl-6-hydroxymethyl-1-nitrobenzene
• CAS: 80866-76-8
• 化学式: C₈H₉NO₃
• mdl: MFCD00007182
• 分子量: 167.164
• InChiKey: NELPTBUSFQMYOB-UHFFFAOYSA-N

物化性质

• 熔点：
  48-50 °C(lit.)
• 沸点：
  295.73°C (rough estimate)
• 密度：
  1.2917 (rough estimate)
• 闪点：
  >230 °F
• 稳定性/保质期：

  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  66
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 安全说明：
  S24/25
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2906299090
• 危险性防范说明：
  P264,P280,P302+P352,P337+P313,P362+P364,P332+P313
• 危险性描述：
  H315,H319
• 储存条件：
  存放于阴凉干燥处

SDS

Name:	3-Methyl-2-Nitrobenzyl Alcohol 98% Material Safety Data Sheet
Synonym:	None Known
CAS:	80866-76-8

Section 1 - Chemical Product MSDS Name:3-Methyl-2-Nitrobenzyl Alcohol 98% Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
80866-76-8	3-Methyl-2-Nitrobenzyl Alcohol	98%	279-579-9

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Dusts at sufficient concentrations can form explosive mixtures with air. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use agent most appropriate to extinguish fire.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Exposure Limits CAS# 80866-76-8: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize contact with skin.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: slightly brown
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 42.00 - 47.00 deg C
Autoignition Temperature: Not available.
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H9NO3
Molecular Weight: 167.16

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents, acids, acid anhydrides, acid chlorides.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 80866-76-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-Methyl-2-Nitrobenzyl Alcohol - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 80866-76-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 80866-76-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 80866-76-8 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-甲基-2-硝基苄醇 在 盐酸 、 4-二甲氨基吡啶 、 硼烷四氢呋喃络合物 、 水 、 对甲苯磺酰氯 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 、 水 为溶剂， 反应 15.0h， 生成 2-(3-methyl-2-nitrophenyl)-ethanol
  参考文献：
  名称：

  N-芳基取代基上的侧链烷氧基提高了咪唑基亚烷基催化剂对Enal和Aldehyde的均烯酸酯环化反应的效率。

  摘要：

  由咪唑基亚烷基催化剂和α，β-不饱和醛在四面体中间体中进行的氢转移形成了共轭Breslow中间体。这是关键步骤，它通过向芳基醛中添加均烯酸酯来影响NHC催化的γ-丁内酯的形成效率。一种新型的邻位烷氧基侧基的咪唑基亚烷基催化剂描述了-N-芳基。这种催化剂有助于形成共轭的Breslow中间体。对提供γ-丁内酯的均烯酸酯环化反应速率常数的研究表明，在N-芳基取代基的适当位置引入氧原子可以提高咪唑基亚烷基催化剂的效率。结构和机理研究表明，烷氧基侧基可以靠近四面体中间体的质子，从而促进质子转移。

  DOI：

  10.1002/anie.202008631
• 作为产物：
  描述：

  3-甲基-2-硝基苯甲酰氯 在 sodium tetrahydroborate 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 以61%的产率得到3-甲基-2-硝基苄醇
  参考文献：
  名称：

  异构体甲酰基-2,1-苯并恶唑的制备与反应

  摘要：

  制备了新型的4-甲酰基-2，1-苯并恶唑和7-甲酰基-2，1-苯并恶唑，用于通过汉茨化学合成法转化为1，4-二氢吡啶。4-甲酰基衍生物有效地环化成二氢吡啶，而已证明7-甲酰基化合物的类似反应是有问题的。

  DOI：

  10.1002/jhet.5570230347

文献信息

• SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
  申请人：Luzzio Michael Joseph

  公开号：US20090054395A1

  公开（公告）日：2009-02-26

  The present invention relates to a compound of the formula I wherein R 1 to R 6 , A, B, n and m are as defined herein. Such novel sulfonyl amide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.

  本发明涉及一种具有以下式I的化合物 其中R 1 至R 6 ，A，B，n和m如本文所定义。这种新型磺酰胺衍生物在治疗哺乳动物（如癌症）中的异常细胞生长方面是有用的。本发明还涉及一种在治疗哺乳动物（尤其是人类）中的异常细胞生长中使用这种化合物的方法，以及含有这种化合物的药物组合物。
• HIV protease inhibiting compounds
  申请人：DeGoey A. David

  公开号：US20050148623A1

  公开（公告）日：2005-07-07

  A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

  披露了一种公式的化合物作为HIV蛋白酶抑制剂。还披露了用于抑制HIV感染的方法和组合物。
• Benzimidazole derivative
  申请人：Tsuchiya Naoki

  公开号：US20050267148A1

  公开（公告）日：2005-12-01

  The present invention is a thiobenzimidazole derivative represented by the following formula (1) or a medically acceptable salt thereof wherein said thiobenzimidazole derivative and a medically acceptable salt thereof have a potent activity of inhibiting human chymase. Thus, they are potential preventive and/or therapeutic agents clinically applicable to various diseases in which human chymase is involved.

  本发明是一种由以下式（1）表示的硫苯并咪唑衍生物或其医学上可接受的盐，其中所述的硫苯并咪唑衍生物及其医学上可接受的盐具有抑制人体胰蛋白酶的强效活性。因此，它们是潜在的预防和/或治疗剂，可在涉及人体胰蛋白酶的各种疾病中进行临床应用。
• Tandem catalytic oxidative deacetylation of acetoacetic esters and heteroaromatic cyclizations
  作者：Yeming Ju、Di Miao、Ruiyang Yu、Sangho Koo

  DOI：10.1039/c4ob02441a

  日期：——

  One pot syntheses of furan, thiophene, and pyrrole were accomplished by oxidative deacetylation using Mn(III)/Co(II) catalysts and the Paal–Knorr reaction from 1,5-dicarbonyl compounds, which are prepared from the conjugate addition of ethyl acetoacetate to α,β-unsaturated carbonyl compounds. The oxidative deacetylation and reductive cyclization of β-ketoesters derived from ethyl acetoacetate and o-nitrobenzyl

  一锅合成呋喃，噻吩和吡咯是通过使用Mn（III）/ Co（II）催化剂进行氧化脱乙酰作用以及1,5-二羰基化合物的Paal-Knorr反应完成的，该反应是通过乙酰乙酸乙酯的共轭加成制备的α，β-不饱和羰基化合物。衍生自乙酰乙酸乙酯和邻硝基苄基溴化物的β-酮酸酯的氧化脱乙酰基和还原环化有效地产生了各种取代的吲哚。
• [EN] PHENYLALKYL AND PYRIDYLALKYL PIPERAZINE DERIVATIVES<br/>[FR] DERIVES DE PIPERAZINE PHENYLALKYLES ET PYRIDYLALKYLES
  申请人：WARNER LAMBERT CO

  公开号：WO2004041793A1

  公开（公告）日：2004-05-21

  This invention relates to compounds of the formula (1) wherein R?1, R3, R4, X1, and X2¿ are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system and other disorders.

  这项发明涉及公式（1）中的化合物，其中R1、R3、R4、X1和X2的定义如规范中所述，包含它们的药物组合物以及它们在治疗中枢神经系统和其他疾病中的用途。

表征谱图